Results 81 to 90 of about 2,050 (152)
BMC Microbiology, 2020 Background Acinetobacter baumannii is a multidrug-resistant (MDR) hazardous bacterium with very high antimicrobial resistance profiles. Outer membrane vesicles (OMVs) help directly and/or indirectly towards antibiotic resistance in these organisms.
DineshKumar Kesavan +6 more
doaj +1 more source
, 2016 Eravacycline and comparators were tested against carbapenem- and tigecycline-resistant Enterobacteriaceae and Acinetobacter received at the United Kingdom's national reference laboratory Eravacycline MICs correlated closely with those of tigecycline but ...
Warner, Marina +3 more
core +1 more source
Viability of UPEC normal, persister and biofilm cells after treatment with eravacycline.
, 2021 (A) Effects on the viability of planktonic normal (black bars) and persister (patterned bars) cells of UPEC. Means ± SE are shown (n>3). (B) Effects on 48-h UPEC biofilms.
Karin Sauer (1993) +5 more
core +1 more source
Transplant Infectious Disease, Volume 26, Issue 6, December 2024.Vancomycin‐resistant Enterococci infections carry high mortality in liver transplant recipients, especially in the setting of daptomycin resistance. Infection relapsed or recurred in over 25% despite standard‐of‐care therapy. Source control is critical and more data is needed to establish an optimal treatment approach.
Aldo Barajas‐Ochoa +8 more
wiley +1 more source
Infection and Drug Resistance, 2023 Xuehan Zou,1,* Shaojun Jin,2,* Lingxia Chen,1,* Jie Li,1 Xiaofan Zhang,3 Hua Zhou,4 Xi Li,3 Haijun Huang1 1Center for General Practice Medicine, Department of Infectious Diseases, Zhejiang Provincial People’s Hospital, Affiliated People’s ...
Zou X +7 more
doaj
Infection and Drug Resistance, 2022 Qian Zhou,1,2,* Wenqi Xu,1,2,* Xiaoyu Zhu,1,2 Jin Zhang,1,2 Yan Zhang,1,2 Yan Han,1,2 Kai Chen,1,2 Yueping Yin1,2 1Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, People’s Republic of China;
Zhou Q +7 more
doaj
IGNITE4 : Results of a phase 3, randomized, multicenter, prospective trial of eravacycline vs meropenem in the treatment of complicated intraabdominal infections [PDF]
, 2019 Funding Information: Financial support. This work was supported by Tetraphase Pharmaceuticals Inc. Funding Information: Potential conflicts of interest. J. S. S. has received support from Tetraphase Pharmaceuticals Inc.
Tsai, Larry +6 more
core +1 more source
, 2021 There are no published studies documenting outcomes with the use of eravacycline against drug-resistant Acinetobacter baumannii. The purpose of this study is to assess the efficacy of eravacycline use, in comparison to best previously available therapy ...
Zhu, Elizabeth +3 more
core
, 2020 Additional file 3.DEGs of eravacycline treated and control strains of A.
Zhaoliang Su (396851) +6 more
core +1 more source
In vitro efficacy of eravacycline on carbapenem-resistant
, 2022 Enterobakterije otporne na karbapeneme (eng. Carbapenem-Resistant Enterobacteriaceae, CRE) su razvile sposobnost stvaranja beta-laktamaza KPC, VIM, NDM i OXA-48 zbog sve veće uporabe karbapenema u kliničkoj praksi te predstavljaju veliku opasnost za ...
Jurić, Ivana
core